These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10221788)

  • 1. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability.
    Christian L; Snycerski SM; Singh NN; Poling A
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():88-93. PubMed ID: 10221788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic drug use among people with intellectual disability before and after deinstitutionalization.
    Nøttestad JA; Linaker OM
    J Intellect Disabil Res; 2003 Sep; 47(Pt 6):464-71. PubMed ID: 12919197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution.
    Kelly S; Su Y
    Intellect Dev Disabil; 2015 Aug; 53(4):289-300. PubMed ID: 26214558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staff perceptions following a training programme about reducing psychotropic medication use in adults with intellectual disability: The need for a realistic professional practice framework.
    Barratt M; Jorgensen M; Deb SS; Limbu B; Donley M; Buchholtz M; Smith V; Wilson N
    J Appl Res Intellect Disabil; 2023 May; 36(3):486-496. PubMed ID: 36655535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
    Shankar R; Wilcock M
    PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
    Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
    J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training support workers about the overmedication of people with intellectual disabilities: an Australian pre-post pilot study.
    Wilson NJ; Barratt M; Jorgensen M; Limbu B; Donley M; Buchholtz M; Smith V; Deb S
    J Intellect Disabil Res; 2023 Jun; 67(6):519-530. PubMed ID: 36880447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors.
    García-Domínguez L; Navas P; Verdugo MÁ; Arias VB; Gómez LE
    J Appl Res Intellect Disabil; 2022 Sep; 35(5):1109-1118. PubMed ID: 35384179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded.
    Aman MG; Singh NN; Fitzpatrick J
    J Autism Dev Disord; 1987 Dec; 17(4):511-23. PubMed ID: 3680153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
    de Kuijper G; Degraeve G; Zinkstok JR
    Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caregiver perceptions of psychotropic medication in residential facilities.
    Aman MG; Singh NN; White AJ
    Res Dev Disabil; 1987; 8(3):449-65. PubMed ID: 3671821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do people with intellectual disabilities, their family members and paid carers understand about psychotropic medication? A rapid review.
    Cavanagh DE; Caton S; Rawles J; Runswick-Cole K; Hatton C; Chauhan U; Hutchinson C
    J Appl Res Intellect Disabil; 2024 Sep; 37(5):e13283. PubMed ID: 39039824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK.
    Sheehan R; Hassiotis A; Strydom A; Morant N
    BMJ Open; 2019 Nov; 9(11):e032861. PubMed ID: 31780594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities.
    de Kuijper G; van der Putten AAJ
    J Appl Res Intellect Disabil; 2017 Dec; 30 Suppl 1():1-9. PubMed ID: 28467003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-Term Psycho-Education for Caregivers to Reduce Overmedication of People with Intellectual Disabilities (SPECTROM): Development and Field Testing.
    Deb SS; Limbu B; Unwin G; Woodcock L; Cooper V; Fullerton M
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.